Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
1,264
-
Total 13F shares, excl. options
-
91,348,974
-
Shares change
-
+171,553
-
Total reported value, excl. options
-
$80,250,681,450
-
Value change
-
+$167,710,733
-
Put/Call ratio
-
143%
-
Number of buys
-
542
-
Number of sells
-
507
-
Price
-
$878.29
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2023
As of 31 Dec 2023 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 1,412 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 91,348,974 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Capital World Investors, STATE STREET CORP, Capital International Investors, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, and LOOMIS SAYLES & CO L P.
This table shows 1,412 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.